Bhlha15-CreERT2
Nomenclature
C57BL/6Smoc-Bhlha15em1(CreERT2)Smoc
Cat. NO.
NM-KI-200080
Strain State
Repository Live
Gene Summary
Gene Symbol
Bhlha15
Model Description
Validation Data
Fig. 1 CreERT2-mediated recombination in the intestine of Bhlha15CreERT2/+; Rosa26tdTomato/+ mouse. TdTomato(red) expression can be detected in the crypt of Bhlha15CreERT2/+; Rosa26tdTomato/+ mouse after tamoxifen treatment.
Fig. 2 CreERT2-mediated recombination in the pancreas of Bhlha15CreERT2/+; Rosa26tdTomato/+ mouse. TdTomato(red) expression can be detected in the pancreas of Bhlha15CreERT2/+; Rosa26tdTomato/+ mouse after tamoxifen treatment. Some leakiness can be detected in the pancreas prior to tamoxifen treatment.
Fig. 3 Detection of tdTomato(red) in various tissues of Bhlha15CreERT2/+; Rosa26tdTomato/+ mice. Tdtomato is expressed in the pancreas, pituitary, stomach, crypt, salivary gland, lung, spleen, liver and kidney after tamoxifen treatment. Some leakiness can be detected in the salivary gland and pancreas prior to tamoxifen treatment. Tdtomato expression can not be observed in the brain, colon, heart, retina and skin. (For more detailed information please contact our technical advisor.)
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreAt GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more